Literature DB >> 19907362

High incidence of recurrent wheeze in children with down syndrome with and without previous respiratory syncytial virus lower respiratory tract infection.

Beatrijs L P Bloemers1, A Marceline van Furth, Michel E Weijerman, Reinoud J B J Gemke, Chantal J M Broers, Jan L L Kimpen, Louis Bont.   

Abstract

BACKGROUND: Respiratory syncytial virus (RSV)-induced lower respiratory tract infection (LRTI) is associated with the subsequent development of recurrent wheeze. In a recent study, we found a high incidence (9.9%) of hospitalization for RSV-induced LRTI among children with Down syndrome (DS), indicating DS as a new risk factor for RSV-induced LRTI. In the current study we aimed to investigate the development of long-term airway morbidity in children with DS after hospitalization for RSV-induced LRTI.
METHODS: A combined retrospective cohort and prospective birth cohort of children with DS with a history of hospitalization for RSV-induced LRTI was studied (n = 53). Three control populations were included: children with DS without hospitalization for RSV-induced LRTI (n = 110), children without DS but with hospitalization for RSV-induced LRTI (n = 48), and healthy siblings of the previous 3 groups mentioned (n = 49). The primary outcome was physician-diagnosed wheeze up to 2 years of age.
RESULTS: The incidence of physician-diagnosed recurrent wheeze in children with DS with a history of hospitalization for RSV-induced LRTI was 36%. Unexpectedly, up to 30% of children with DS without a history of RSV-induced LRTI had physician-diagnosed recurrent wheeze (no significant difference). In children without DS physician-diagnosed wheeze was found more frequently in children hospitalized for RSV-induced LRTI than healthy controls (31% vs. 8%, P = 0.004).
CONCLUSIONS: In this combined retrospective/prospective cohort study RSV-induced LRTI did not significantly contribute to the risk of recurrent wheeze in children with DS. An unexpected finding was that recurrent wheeze was very common among children with DS.

Entities:  

Mesh:

Year:  2010        PMID: 19907362     DOI: 10.1097/INF.0b013e3181b34e52

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  13 in total

1.  Preventing hospitalizations for respiratory syncytial virus infection.

Authors:  Joan L Robinson; Nicole Le Saux
Journal:  Paediatr Child Health       Date:  2015 Aug-Sep       Impact factor: 2.253

Review 2.  Infections and immunodeficiency in Down syndrome.

Authors:  G Ram; J Chinen
Journal:  Clin Exp Immunol       Date:  2011-02-24       Impact factor: 4.330

Review 3.  Clinical practice. The care of children with Down syndrome.

Authors:  Michel E Weijerman; J Peter de Winter
Journal:  Eur J Pediatr       Date:  2010-07-15       Impact factor: 3.183

4.  Risk factors for severe respiratory syncytial virus lower respiratory tract infection.

Authors:  Constanze Sommer; Bernhard Resch; Eric A F Simões
Journal:  Open Microbiol J       Date:  2011-12-30

5.  Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populations.

Authors:  B Paes; I Mitchell; A Li; K L Lanctôt
Journal:  Eur J Pediatr       Date:  2011-12-28       Impact factor: 3.183

6.  Comment on 'Allergy and acute leukaemia in children with Down syndrome: a population study. Report from the Mexican Inter Institutional Group for the Identification of the Causes of Childhood Leukaemia (MIGICCL)'--is increased surveillance by hypersensitive immune system a reality or myth?

Authors:  Z Aryan; N Rezaei
Journal:  Br J Cancer       Date:  2013-08-01       Impact factor: 7.640

Review 7.  The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood.

Authors:  Brigitte Fauroux; Eric A F Simões; Paul A Checchia; Bosco Paes; Josep Figueras-Aloy; Paolo Manzoni; Louis Bont; Xavier Carbonell-Estrany
Journal:  Infect Dis Ther       Date:  2017-03-29

8.  Allergy and acute leukaemia in children with Down syndrome: a population study. Report from the Mexican inter-institutional group for the identification of the causes of childhood leukaemia.

Authors:  J C Núñez-Enríquez; A Fajardo-Gutiérrez; E P Buchán-Durán; R Bernáldez-Ríos; A Medina-Sansón; E Jiménez-Hernández; R Amador-Sanchez; J G Peñaloza-Gonzalez; R Paredes-Aguilera; F J Alvarez-Rodriguez; V Bolea-Murga; J de Diego Flores-Chapa; J Flores-Lujano; V C Bekker-Mendez; R Rivera-Luna; M Del Carmen Rodriguez-Zepeda; A Rangel-López; E M Dorantes-Acosta; N Núñez-Villegas; M M Velazquez-Aviña; J R Torres-Nava; N C Reyes-Zepeda; R Cárdenas-Cardos; L V Flores-Villegas; A Martinez-Avalos; F Salamanca-Gómez; C Gorodezky; J Arellano-Galindo; J M Mejía-Aranguré
Journal:  Br J Cancer       Date:  2013-05-21       Impact factor: 7.640

9.  Increased risk of RSV infection in children with Down's syndrome: clinical implementation of prophylaxis in the European Union.

Authors:  Dianne van Beek; Bosco Paes; Louis Bont
Journal:  Clin Dev Immunol       Date:  2013-06-25

10.  Epidemiology of respiratory symptoms in children with Down syndrome: a nationwide prospective web-based parent-reported study.

Authors:  Ruud H J Verstegen; Roeland W N M van Hout; Esther de Vries
Journal:  BMC Pediatr       Date:  2014-04-15       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.